Base to Base Biotech

This week, three interviews, and five guests. We have conversations with Ulrik Tirsted Zeuthen, CEO, and Katarina Cantell, founder/CSO of Adalyon; Nisit Khandelwal, co-founder/CEO, Cycuria Therapeutics; and Craig Ritchie, founder/CEO of Scottish Brain Sciences and Deborah O’Neil, CEO/CSO of NovaBiotics as well as chair of the Life Sciences board of Opportunity Northeast, which runs ONE BioHub, and...

This week, we’re talking about eye treatments with Oculis CEO, Riad Sherif, we have a conversation about mitochondria, with the CEO of Vandria, Klaus Dugi, and there’s also a short discussion about GoCo Health Innovation City in Gothenburg, Sweden, with Moa Dicksdotter, Partnership and Ecosystem. Times: 02:35 Vandria 20:03 GoCo Health Innovation City 25:54 Oculis Looking to the eyes Oculis is a Sw...

This week, we’re talking about skin and wounds, with Ned Swanson, president and chief medical officer at PolarityBio, and Nikolai Sopko, chief operating officer, chief scientific officer and director at PolarityBio; and we discuss anchored immunotherapy with Howard Kaufman, CEO of Ankyra Therapeutics. 04:03 Ankyra Therapeutics 34:31 PolarityBio Anchored immunotherapies Ankyra Therapeutics , based...

This week, we have conversations with Jakob Andersson, vice president of engineering at Anaphora and founder and chairman of GAIA; Coave Therapeutics’ CEO Rodolphe Clerval; and MOBILion Systems’ CEO, Melissa Sherman. Times: 03:13 Coave Therapeutics 24:43 GAIA Conference 36:55 MOBILion Systems Genetic medicine for ophthalmology Coave Therapeutics is a Paris‑based biotechnology company focused on de...

This week, we have conversations with Sjanna Bosma, international relations officer at Health Holland; Mark Bagnall, CEO of Phenomix; and PDS Biotechnology CEO Frank Bedu-Addo. 04:17 Phenomix 32:53 Health Holland 44:02 PDS Biotechnology Phenomix takes on obesity Phenomix Sciences is a biotechnology company focused on precision obesity medicine. The firm has developed the MyPhenome test, a saliva‑b...

This week, we have conversations with Jérôme Van Biervliet, chair of the board of Flanders life sciences body Biovia and managing director at VIB; Sylvain Sachot, partner at Asabys Partners; and Jonas Béal, head of science strategy, R&D, at Owkin. 03:32 Owkin 27:42 Biovia/VIB 38:06 Asabys Partners Biovia/VIB Biovia has emerged as a new health innovation cluster in the Belgian region of Flander...

This week, we have conversations with Robert Bunn, founder and president of Ultrasound AI; Laura MacNeill, CEO of the Charcot Marie Tooth Research Foundation; and Iris Örhn, investment advisor at Business Region Göteborg. 03:00 Ultrasound AI 30:19 Business Region Gothenburg 39:35 CMTRF Business Region Gothenburg Business Region Gothenburg (BRG) is the regional development agency for western Sweden...

This week, we have conversations with Malin Kjällström, Gothenburg Tech Week Press and partnerships lead; Eliot Forster the CEO of Levicept; and Christophe Demaison, CEO of ENA Respiratory. Gothenburg Tech Week Gothenburg Tech Week is western Sweden’s largest technology event, held annually across multiple venues in the city. The 2025 edition ran from October 14–16, with a programme that includes...

It’s World Immunization Day on Monday, so we had a chat with Geovax chairman, president and CEO David Dodd, and in our other conversation, we talked about infertility, with Igyxos Biotherapeutics’ chief medical officer Elke Bestel. Challenging infertility Igyxos Biotherapeutics is a French biotechnology company founded in 2017 and based in Nouzilly, France. The company focuses exclusively on infer...

This week, we have conversations with Cosmo Feilding Mellen, CEO of Beckley Psytech; Sirli Rosenvald, CEO of Estonian company Funki, and Per von Mentzer, CEO of Swedish company PharmNovo. We spoke with Funki at Life Sciences Baltics in Vilnius, Lithuania, recently, and with von Mentzer at NLS Days in Gothenburg. Taking on pain PharmNovo AB is a biotechnology company headquartered at Medicon Villag...

This week, we have conversations on data integration with Lithuanian company Vugene, and we talk protein degradation with Amphista Therapeutics. Multi-omics Vugene is a Lithuanian bioinformatics company focused on multi-omics data integration. Founded in 2021 by CTO Juozas Gordevičius, the company is headquartered in Kaunas. Its core offering is a software platform designed to help researchers mak...

This week, we have one interview, covering enzymes and AI with Biomatter Designs, from our visit to Life Sciences Baltics in Vilnius, Lithuania recently. And from the trip to Dublin in Ireland we talked about technology that can be useful in neurological condition diagnosis, and much more, with Danu Sports. Enzymes and AI Biomatter Designs is a Lithuania‑based biotech working at the frontier of pr...

This week, we have three interviews done during Life Sciences Baltics, which was held in Vilnius, Lithuania recently. While we have more still to come, this week on the podcast we have conversations with Justinas Mačiulaitis, Keli Therapeutics’ founder and CEO; Arnas Karužas, CEO of Ligence; and Emilė Radytė, CEO and co-founder of Samphire Neuroscience. Ligence Ligence is a health‑tech startup usi...

This week, we have two interviews again. We talk about treating high blood pressure with CEO of George Medicines, Mark Mallon, and have a conversation with Jack Hoppin, CEO of Ratio Therapeutics, and John Babich, CSO, about the field of radiotherapeutics. Blood pressure Nearly half of US adults have high blood pressure and despite all the treatments already available, three in four remain uncontro...

This week, we have two interviews. We chat with Step Pharma CEO, Andy Parker, and also have a conversation with Re-Vana CEO, Michael O’Rourke. Ocular therapeutics Re-Vana Therapeutics and Boehringer Ingelheim recently announced a $1bn+ deal to develop long-acting ophthalmic therapies. Re-Vana Therapeutics is a privately held, US and UK based developer of ocular therapeutics and innovative ocular d...

This week, we have two interviews: one to mark Childhood Cancer Awareness Month, on osteosarcoma with Paul Romness from OS Therapies; and IMUNON’s CEO, Stacy Lindborg, talking about ovarian cancer, immunotherapy, covid, and more. Interview times: 02:33 OS Therapies 23:03 IMUNON Challenging osteosarcoma OS Therapies is a clinical stage oncology company focused on the identification, development, an...

This week, we have three interviews to mark Stand Up To Cancer Day. We have conversations with Simon Kerry, co-founder and CEO of Curve Therapeutics; Poolbeg Pharma CEO Jeremy Skillington; and Stefano Gulla, CSO of Kling Biotherapeutics. Interview times: 03:12 Curve Therapeutics 21:32 Kling Bio 37:10 Poolbeg Pharma Microcycles to address cancer Curve Therapeutics , a private biotechnology company...

This week, we have an in-depth conversation on molecular glue degradation, with Monte Rosa Therapeutics’ chief data and information officer John Castle. Interview time: 03:52 Monte Rosa Therapeutics Molecular glue degradation A recent cover article in Science showcased research that expands by more than 1,000 the number of therapeutic targets (including undruggables) accessible through a protein d...

This week, we look at Herantis Pharma's work on Parkinson's disease, with the company's CEO, Antti Vuolanto, and we have an in-depth look at the recent cuts to mRNA vaccine projects, with Jean Peccoud, GenoFAB founder and professor at Colorado State University. Interview times: 03:22 Herantis 16:28 mRNA cuts Cuts to mRNA vaccine projects The U.S. Department of Health and Human Services (HHS) recen...

This week, we have a wide-ranging conversation with Anna Codina, senior director strategy and business development at SciY (part of Bruker), as we discuss artificial intelligence, and digitalisation, and the effect on labs. We also chat with Fibrobiologics’ CEO Pete O'Heeron about fibroblast spheroid technology. Interview times: 03:49 FibroBiologics 21:26 SciY SciY on the path to digitalisation Th...

This week, we talk about new treatments for wet dry age-related macular degeneration (AMD) with Judith Greciet, CEO of PulseSight Therapeutics, and there’s a conversation with Maite Agüeros, CEO and co-founder of InnoUp Farma about, among other things, peanut allergies. Interview times: 03:24 PulseSight 20:43 InnoUp Tackling dry AMD PulseSight Therapeutics SAS, an ophthalmology biotech company dev...

This week, we talk about drug discovery with Shinya Yuki, co-founder and CEO of Elix Inc., and Teresa Whalen, CEO of CytoAgents, about CAR-T therapies, cytokine release syndrome, and the FDA. Interview times: 03:53 Elix 20:58 CytoAgents Elix drug discovery platform AI drug discovery company Elix, Inc . and the Life Intelligence Consortium (LINC) have announced that for the first time in the world,...

This week, our conversations are with Wenyan Leong, director of APAC commercial and global strategic partnerships for cell and gene therapies at Terumo Blood and Cell Technologies, and Morten Graugaard, CEO of Orbis Medicines. Interview times: 04:01 Terumo BCT 24:52 Orbis Medicines Terumo Blood and Cell Technologies shows integrated 3-in-1 CAR-T workflow with quantum platform Terumo Blood and Cell...

This week’s podcast is sponsored by Nipro . This week, our conversations are with Jesus Garcia, Nipro Product Manager Water Treatment, on Nipro ’s recently-launched product LiniXia, a reverse osmosis (RO) system that ensures safe and pure water for every dialysis session, and on the future of biologics manufacturing with cell-free protein synthesis with LenioBio CEO André Goerke. Interview times:...

This week, we have conversations with Eduardo Bravo, CEO of Citryll, and Dermot Tierney, COO of AMPLY Discovery. Interview times: 02:53 Citryll 21:56 AMPLY Discovery Citryll Citryll ’s recent Series B financing of €85m at the end of last year is helping to advance its first-in-class therapy targeting neutrophil extracellular traps (NETs). Discovered in 2004, NETs are web-like structures released b...